Daily Stock List
Commerce Resources Corp. (CCE.V)
We are reporting on Commerce Resources Corp. (CCE.V), here at the QualityStocks Daily Newsletter.
Commerce Resources Corp. is an exploration and development company headquartered in Vancouver, British Columbia (B.C.). The Company has a particular focus on deposits of rare metals and rare earth elements (REEs). They are concentrating on the development of their Upper Fir Tantalum and Niobium Deposit in B.C. and the Ashram Rare Earth Element Deposit in northern Quebec. The Company has a specific focus on tantalum, niobium and rare metal deposits with potential for economic grades and large tonnages. Commerce Resources lists on the TSX Venture Exchange and the OTCQX International (CMRZF).
Commerce Resources successfully completed Preliminary Economic Assessments (PEAs) for the Blue River and Ashram Projects. Work programs continue to advance both projects towards the next stages of development. In 2011, they completed the positive PEA on the Upper Fir Deposit of the Blue River Tantalum-Niobium Project.
One highlight of this study is that the PEA results show a positive cash flow for a potential 7500 tonnes per day underground operation at the Upper Fir Deposit. The PEA also identified opportunities for optimization in the geology and mining areas. The Blue River Tantalum-Niobium Project is surrounded by geologically fertile mineral claims that are also wholly owned by Commerce Resources.
In 2012, Commerce Resources completed a positive PEA on the Eldor Rare Earth Project in northern Quebec. Highlights of the study include a strongly positive cash flow from a 4,000 tonne per day open-pit operation at Ashram with a 25-year mine life.
In late March of this year, Commerce Resources provided a further update on work completed at the Company's Blue River Project since release of the National Instrument (NI) 43-101 compliant Mineral Resource update (Commerce Resources news release July 6, 2012) for the Upper Fir Deposit. Newly completed mineralogical variability studies show that the partially optimized flotation flow sheet which formed the base of the metallurgical analysis in the Preliminary Economic Assessment (PEA), and which was further optimized during Phase 2 test work (reported December 3, 3012) shows good applicability across the range of mineralogies tested.
Commerce Resources Corp. (CCE.V), closed Thursday's session at $0.07, up 7.69%, on 106,000 volume. The stock's 52-week low/high is $0.073/$0.163.
Dynamic Applications Corp. (DYAP)
OTCPicks, Stock Traders Chat, MicrocapVoice, ChartAdvisor, StockEgg, HotOTC, and The Stock Prophet reported previously on Dynamic Applications Corp. (DYAP), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
OTCPicks, Stock Traders Chat, MicrocapVoice, ChartAdvisor, StockEgg, HotOTC, and The Stock Prophet reported previously on Dynamic Applications Corp. (DYAP), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTC Markets' OTCQB, Dynamic Applications Corp. (a development stage company) is the North American representative of Sensoil Innovations Ltd. SenSoil's contamination detection and remediation technology exists in more than 15 commercial installations globally. SenSoil Innovations has more than $4.2 Million in accumulated sales and two global patents. In addition, Dynamic Applications owns a U.S. patent for a unique electromagnetic percussion device that the Company is developing with a major Israeli industrial manufacturer for international sale. Founded in 2008, Dynamic Applications has their corporate headquarters in Jerusalem, Israel.
On April 17, 2013, Dynamic Applications entered into an agreement with SenSoil Innovations. SenSoil VMS™ Vadose-Zone Monitoring technology is for the soil contamination and purification industry. This technology provides early detection, better prevention, and streamlined optimization for existing soil remediation procedures. The Representative Agreement with Sensoil Innovations is part of Dynamic Applications' plan to enhance their revenue stream through entering into joint ventures (JVs) or other business arrangements with third parties engaged in technology development.
In addition, pertaining to the aforementioned electromagnetic percussion device, Dynamic Applications believes that their patented device has substantial competitive advantages with many potential commercial applications. This device incorporates design features unlike traditional electromagnetic devices, by reversing the positions of the coil and active body, and therefore enhancing durability. The Company's particular patent technology covers the design and development of this electromagnetic percussion device with a striking piston made of a single monolithic block.
The Company has entered into an agreement with GUMI Tel Aviv, Ltd. Their agreement with GUMI provides for their development and manufacture of a final prototype and the worldwide marketing of commercial models of this patented percussion device. GUMI Tel Aviv is a major, privately held Israeli technology company that engages in the design, manufacture, import/export, distribution and installation of industrial equipment for Israeli and international customers.
Dynamic Applications Corp. (DYAP), closed Thursday's trading session at $0.2775, up 4.72%, on 106,000 volume with 7 trades. The average volume for the last 60 days is 6,471 and the stock's 52-week low/high is $0.005/$0.265.
Real Estate Contacts, Inc. (REAC)
Greenbackers and Penny Stocks VIP reported recently on Real Estate Contacts, Inc. (REAC), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Real Estate Contacts, Inc. conducts an online real estate advertising and marketing real estate website. This includes a real estate video listings network. The Company has their real estate search portal (www.realestatecontacts.com). Real Estate Contacts objective is to become one of the leading marketing partners to the real estate industry. The Company is based in New Castle, Pennsylvania; their shares trade on the OTC Markets' OTCQB.
The Company's strategy is a user-friendly approach that allows the consumer to view listings of homes from the website and video channel of their local real estate office or agent. Additionally, their website will feature no more than five agents per territory. Their policy in this regard will eliminate a major amount of the competition for the real estate agent, broker and office. The Company believes that their concept will have a high level of interest from real estate professionals.
RealEstateContacts.com is not in the real estate business. Therefore, they do not compete against professional real estate brokers or agents. Real Estate Contacts conducts their business solely within the internet and the online video arena. This includes their real estate search engine, social community, as well as video real estate network. They match buyers, sellers, brokers and professionals anywhere in the world via their portal website.
The RealEstateContacts.com site consists of an assortment of well-known and local independently owned and operated franchisees of the nation's leading real estate companies. It also consists of individual real estate agents, local mortgage brokers and national mortgage lenders.
At the end of April, Real Estate Contacts announced that they started their initial beta testing of their brand new video website service on realestatevideochannels.com. Currently, the Company is looking for real estate agents to help test the service free. This website will provide real estate agents their own unique URLs and create an easy system to upload their listings in video and create their own selling video channels. Additional ad revenues when generated will be shared with the real estate agent, further reducing the cost of using the service.
Real Estate Contacts, Inc. (REAC), closed Thursday at $0.0032, up 45.45%, on 21,809,105 volume with 79 trades. The average volume for the last 60 days is 9,044,490 and the stock's 52-week low/high is $0.0015/$0.273.
Katanga Mining Ltd. (KAT.TO)
We are reporting on Katanga Mining Ltd. (KAT.TO) today, here at the QualityStocks Daily Newsletter.
Katanga Mining Ltd. operates a major mine complex in the Democratic Republic of Congo (DRC). They produce refined copper and cobalt. Katanga has a large-scale copper-cobalt project with significant high-grade mineral reserves and integrated metallurgical operations. The Company holds a 75 percent stake in two joint ventures with Gécamines, a state-owned mining company in the DRC. Katanga Mining's shares trade on the Toronto Stock Exchange. The Company has their corporate headquarters in Zug, Switzerland.
Katanga Mining operates a large-scale copper-cobalt mine complex in the DRC via two joint ventures, Kamoto Copper Co. (KCC) and DRC Copper and Cobalt Project (DCP). KCC and DCP operate on adjacent properties in the DRC. They are working to create a major single-site copper and cobalt operation. KCC and DCP engage in the exploration, refurbishment and rehabilitation of the Kamoto/Dima mining complex (the Kamoto Project) and the KOV copper and cobalt mine, respectively in the DRC.
The Kamoto Project began commercial production on June 1, 2008. The Kamoto Project includes exploration and mining properties, the Kamoto concentrator, the Luilu metallurgical plant, the Kamoto underground mine, as well as two oxide open pit resources in the Kolwezi district of the DRC. Furthermore, Katanga has several other mines and plants that may be operated initially or at a later stage in the Company's development. These include the open pit mines Mashamba East, Musonoie-T17 and Kananga.
Earlier this month, Katanga Mining announced their financial results for the first quarter of 2013. Total sales for Q1 2013 were $188.1 million; this represents a 40 percent increase over Q1 2012. The realized copper price for Q1 2013 was $3.34 /lb; this represents an 11 percent decrease over Q1 2012. The realized price of cobalt was $9.75 /lb, a 15 percent decrease over Q1 2012.
For Q1 2013, Katanga Mining earned a net income attributable to shareholders of $30.1 million, which is a 70 percent increase over Q1 2012. Cash and cash equivalents as at March 31, 2013 totaled $45.1 million (December 31, 2012 - $57.0 million).
Katanga Mining Ltd. (KAT.TO), closed at $0.72, up 1.41%, on 11,300 volume. The stock's 52-week low/high is $0.41/$1.07.
Graphite One Resources, Inc. (GPH.V)
We are highlighting Graphite One Resources, Inc. (GPH.V), here at the QualityStocks Daily Newsletter.
Graphite One Resources, Inc. is a mineral exploration company that lists on the TSX Venture Exchange. The Company has wide-ranging experience in the state of Alaska. Their business strategy is to identify, acquire, and explore high potential projects ready for rapid advancement. Graphite One has an option to earn a 100 percent interest in the Graphite Creek Property on the Seward Peninsula of Alaska, 65 kilometers north of Nome.
The Graphite Creek Property offers substantial potential for the discovery and development of a large flake, graphite deposit exposed at surface. The host schist(s) is continuous over 18 kms of strike length, based on mapping and geophysics.
Based on first year drilling of 2.2 km of an 18 km strike length, the Graphite Creek Property has a 43-101 inferred resource of 164.5Mt at 4.61 percent Cg. This includes an at surface high-grade zone of 7.8Mt at 13.5 percent Cg. Graphite Creek has the potential to be the world's largest known large flake graphite deposit.
There is the potential for a multi-million tonne target of 235 - 492 Mt, with grades between 4.2 percent and 7.9 percent Cg at Graphite Creek. The Company believes that the fundamentals for success at Graphite Creek include a stable pro-mining jurisdiction, excellent shipping location to the world's major markets, excellent grades and scalable production potential, low capital expenditure and operating cost, very low strip ratio, high percentage large flake graphite, increasing market demand for graphite, as well as an experienced management team.
At the end of April, Graphite One Resources announced that a first pass beneficiation test at Activation Laboratories Ltd., Thunder Bay, Ontario, demonstrated a leaching process capable of producing a high purity of 99.2 percent graphitic carbon (Cg) from a rough concentrate. Metallurgical test work from Graphite Creek material is continuing to develop a simple concentration and leaching process to produce an ultra-high purity (99.9 percent Cg) graphite product.
With initial tests from Graphite Creek showing recoveries above 99 per cent, Graphite One Resources hopes to be positioned to compete in the $13-billion (1.5 million tonnes annually) synthetic market. The Graphite Creek Property consists of 129 claims totaling 6,799 hectares. Mineralization at this Property is characterized by coarse crystalline (large flake) graphite (greater than 80 mesh) within graphite-bearing schist(s).
Graphite One Resources, Inc. (GPH.V), closed Thursday's trading session at $0.21, up 2.44%, on 588,911 volume. The stock's 52-week low/high is $0.10/$0.27.
Vista Gold Corp. (VGZ.TO)
Today we are reporting on Vista Gold Corp. (VGZ.TO), here at the QualityStocks Daily Newsletter.
Based in Littleton, Colorado, Vista Gold Corp. is an international gold mining company. They are concentrating on the development of the Mt. Todd gold project in Northern Territory, Australia, to achieve their objective of becoming a gold producer. The Company has 5.4 million ounces of proven and probable reserves, 12.5 million ounces of measured and indicated resources, and 3.7 million ounces of inferred resources in a portfolio of five projects. Vista Gold lists on the Toronto Stock Exchange.
Mt. Todd (based on the January 2011 Preliminary Feasibility Study (PFS)) has the potential to produce approximately 250,000 ounces of gold per year over the first five years and an average of 240,000 ounces per year over a projected 14-year mine life. Moreover, Vista Gold is advancing exploration on their Guadalupe de los Reyes gold/silver project in Mexico. They hope that the Guadalupe de los Reyes gold/silver project will demonstrate its potential as a high-grade underground district that can undergo development in succession to the Mt. Todd gold project. Vista has completed a Preliminary Economic Assessment (PEA) on their Guadalupe de los Reyes gold/silver project.
Vista Gold has granted Invecture Group, S.A. de C.V. a right to earn a 62.5 percent interest in the Los Cardones (formerly named Concordia) gold project in Mexico. Vista Gold's other holdings include the Awak Mas gold project in Indonesia, subject to One Asia Resources Ltd.'s right to earn an 80 percent interest, and the Long Valley gold project in California.
Yesterday, Vista Gold announced the positive results of a new Preliminary Feasibility Study (PFS) for their Mt. Todd gold project. The PFS evaluates two development scenarios. These include a 50,000 tonne per day (tpd) project that develops more of the Mt. Todd resource (the Base Case) and generates a larger Net Present Value (NPV), and a smaller and higher-grade 33,000 tpd project that focuses on maximizing return and operating margins (the Alternate Case).
A highlight of the 50,000 tpd Base Case is estimated proven and probable reserves of 5.90 million ounces of gold (223 million tonnes at 0.82 g Au/t) at a cut-off grade of 0.40 g Au/t. This represents an increase of 44 percent from the Company's January 2011 PFS. A highlight of the 33,000 tpd alternate case is estimated proven and probable reserves of 3.56 million ounces of gold (124 million tonnes at 0.90 g Au/t) at a cut-off grade of 0.45 g Au/t.
Vista Gold Corp. (VGZ.TO), closed Thursday's trading at $1.55, up 3.33%, on 28,508 volume. The stock's 52-week low/high is $1.27/$3.99.
Zion Oil & Gas, Inc. (ZN)
Today we are reporting on Zion Oil & Gas, Inc. (ZN), here at the QualityStocks Daily Newsletter.
Established in 2000, Zion Oil & Gas, Inc. is an oil and gas exploration company. Zion explores for oil and gas in Israel in areas situated onshore between Haifa and Tel Aviv. The Company holds three petroleum exploration licenses. A Delaware corporation, Zion Oil & Gas lists on the NASDAQ Global Market. The Company has their corporate headquarters in Dallas, Texas.
Zion Oil & Gas's licenses are situated north of Tel-Aviv and south of Haifa. They extend from the Mediterranean eastward to the Sea of Galilee and the Jordan River. The Company holds 100 percent of the Working Interest (WI) in their licenses. Zion's petroleum exploration licenses include the "Joseph License" (on approximately 83,272 acres), the "Asher-Menashe License" (on approximately 78,824 acres), and the "Jordan Valley License" (on approximately 55,845 acres). These licenses cover approximately 218,000 acres of land in onshore Northern Israel.
Zion Oil & Gas has continuously held the Joseph License since October 2007 and the Asher-Menashe License since June 2007. The Company was awarded the Jordan Valley License in April of 2011. The Joseph License and Asher-Menashe License areas are geographically contiguous and within a similar geologic environment. On April 10, 2013, Zion submitted to Israel's Petroleum Commissioner an application seeking a one-year extension for the Company's existing Joseph License No. 339. On May 12, 2013, the Commissioner notified the Company that their Joseph License was extended until October 10, 2013.
Zion's Net Revenue Interest (NRI) is 81.5 percent. They would receive 81.5 percent of the gross proceeds from the sale of oil and gas produced from lands subject to the licenses (and any leases granted following a declaration of a discovery thereon), if there is any commercial production. The 18.5 percent Zion does not receive is due to a 12.5 percent royalty reserved by the State of Israel and a 6.0 percent royalty to charitable foundations that Zion Oil & Gas established.
In April, Zion Oil & Gas announced that on April 16, 2013, the Company submitted to Israel's Petroleum Commissioner and other Ministry officials an application seeking a Petroleum Exploration License in the Megiddo-Jezreel Valley area, onshore Israel, covering an area of approximately 98,000 acres. As proposed, the Megiddo-Jezreel Valley license area boundary is next to and westward of the Company's existing Jordan Valley License No. 393. If granted, the new Megiddo-Jezreel License would likely be for an initial three-year term with options to extend the license annually up to seven years total.
Zion Oil & Gas, Inc. (ZN), closed today's trading at $1.73, up 1.17%, on 76,393 volume with 183 trades. The average volume for the last 60 days is 78,902 and the stock's 52-week low/high is $0.811/$3.00.
FuelCell Energy, Inc. (FCEL)
Wall Street Resources, Stock Stars, and MonsterStocksPicks reported this week on FuelCell Energy, Inc. (FCEL), SmarTrend Newsletters, Stock Analyzer, StreetInsider, The Street did earlier, and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.
Based in Danbury, Connecticut, FuelCell Energy, Inc. is an integrated fuel cell company. They design, manufacture, install, operate and service stationary fuel cell power plants. FuelCell Energy provides ultra-clean, efficient and reliable baseload distributed generation for electric utilities, commercial and industrial companies, universities, municipalities, government entities and other customers worldwide. FuelCell Energy serves their global markets from a state-of-the-art production facility in Torrington, Connecticut. The Company's shares trade on the Nasdaq Global Market.
FuelCell Energy's power plants have generated more than 1.6 billion kilowatt hours of ultra-clean power utilizing an array of fuels. These include renewable biogas from wastewater treatment and food processing, as well as clean natural gas. Direct FuelCell® (DFC®) power plants are generating power at more than 50 locations around the world. The Company has over 300 megawatts of power generation capacity installed or in backlog.
Their DFC® power plants produce power electrochemically, without burning fuels. This makes them clean, quiet and environmentally responsible alternatives to combustion-based generation. The Company offers a full portfolio of services for fuel cell power plants. Specially trained technicians and engineers remotely operate and maintain nearly their entire installed base of Direct FuelCell power plants around the world, 24 hours per day, 365 days per year. They do so from the state-of-the-art Global Technical Assistance Center located at the Company's Danbury, Connecticut headquarters. The Company's field service technicians service the power plants on-site.
FuelCell Energy offers four power generation solutions designed to meet an assortment of applications. These are DFC300, DFC1500, DFC3000®, and DFC-ERG™. Their DFC300 system is a self-contained electrical power generation system that can provide 300 kilowatts of high-quality baseload power, with 47 percent electrical efficiency, 24 hours a day, 7 days a week.
Their DFC1500 system is a self-contained electrical power generation system. It can provide 1.4 MW of high-quality baseload power at or near the point of use. Their hybrid, multi-megawatt DFC-ERG™ (Direct FuelCell Energy Recovery Generation™) system generates ultra-clean electricity and recovers energy usually lost during natural gas pipeline distribution operations.
Recently, FuelCell Energy announced that they will release their second quarter 2013 financial results after the Market Close on Wednesday, June 5, 2013. Company management will host a conference call with investors starting at 10:00 a.m. Eastern Time (ET) on June 6, 2013 to discuss the second quarter 2013 results.
FuelCell Energy, Inc. (FCEL), closed Thursday's trading session at $1.38, down 4.17%, on 4,499,763 volume with 4,888 trades. The average volume for the last 60 days is 1,680,844 and the stock's 52-week low/high is $0.831/$1.64.
DoMark Internatioxnal, Inc. (DOMK)
The QualityStocks Daily Newsletter would like to spotlight DoMark International, Inc. (DOMK). Today, DoMark International, Inc. closed trading at $0.114, up 54.26%, on 5,979,499 volume with 622 trades. The stock’s average daily volume over the past 60 days is 166,038, and its 52-week low/high is $0.0322/$3.18.
DoMark International, Inc. announced the commencement of design development today on their new revolutionary and extremely lightweight infrared/solar panel charger case for the Apple iPad, which comes with a built in back up lithium battery. Unlike any other product in the market currently, the IRiPad Charger utilizes patented infrared and solar technology designed to improve functionality for the heavy user.
DoMark International, Inc. (DOMK) is focused on researching, evaluating, and acquiring profitable private firms in the business segments of sports, technology, medical, energy, and business services. By providing the financial and human capital necessary to deal with overwhelming administrative, planning, governance, compliance, and regulatory challenges, its newly acquired partners can focus their energy and flourish.
Through its wholly owned subsidiary, SolaWerks, Inc., DoMark is committed to revolutionizing the efficiency and capabilities of a new generation of mobile devices. The subsidiary's current focus is on developing and distributing the SolaPad, a combined cover and charging system for Apple's iPad, and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone.
Musclefoot, Inc., another wholly owned subsidiary of DoMark, is engaged in the distribution, marketing, and sale of Barefoot Science, the revolutionary patented foot care system designed to relieve foot and back pain as well as improve athletic performance. With a strong commitment to customer service and security, DoMark plans to expand its marketing relationships across a far broader product set.
The management team has positioned the company to capitalize on emerging opportunities by working with the world's most forward-thinking companies to develop and market game-changing products with the promise of long-term financial growth. Leveraging the expertise of its team, the company continues to evaluate acquisition candidates and products targeting underserved markets to increase its growth potential. Disclaimer
DoMark International, Inc. Blog
DoMark International, Inc. News:
DoMark International Inc. Develops New Product for $2.3 Billion iPad Accessories Market
DoMark International Inc. Positions Itself for Substantial Growth
Investment in Game Changing New Multi-Media Games Product Developer Imagic Ltd by Smartphone Accessory Supplier DoMark International
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.29, up 0.35%, on 87,544 volume with 34 trades. The stock’s average daily volume over the past 60 days is 120,480, and its 52-week low/high is $0.161/$0.45.
International Stem Cell Corp. announced today the initiation of its IND-enabling pharmacology and toxicology non-human primate studies, under the direction of Yale School of Medicine Professor D. Eugene Redmond Jr. MD, the internationally recognized neurosurgeon and a leader in the use of stem cells for the treatment of Parkinson's disease. The studies will use non-human primates with moderate to severe Parkinson's disease symptoms to assess the safety and functional efficacy of ISCO's proprietary stem cell-derived neuronal cells with primary endpoints to include determining cell fate, biodistribution, and primate behavioral evaluations using a standardized rating scale to assess potential extrapyramidal side effects associated with the cell engraftment.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Initiates IND-Enabling Study in Parkinson's Disease Program
International Stem Cell Corporation to Present at Two Upcoming Investor Conferences
ISCO Announces First Quarter 2013 Financial Results and Provides Business Update
Rainbow Coral Corp. (RBCC)
The QualityStocks Daily Newsletter would like to spotlight Rainbow Coral Corp. (RBCC). Today, Rainbow Coral Corp. closed trading at $0.22, off by 4.35%, on 57,168 volume with 21 trades. The stock’s average daily volume over the past 60 days is 279,856, and its 52-week low/high is $0.10/$4.40.
Rainbow Coral Corp. announced plans today to capture further space in the fast-growing, $232 billion personalized medicine market, including via companion diagnostics, and the company is currently making plans to empower patients to demand better care through a potent combination of innovation and education. CEO of RBCC, Patrick Brown, stated that the company's ultimate goal is to help spur that patient-driven demand for personalized medicine, understanding that it requires not just delivering new innovations, but helping to educate patients on these promising new treatment options and that is why RBCC is developing a comprehensive media and marketing strategy.
Rainbow Coral Corp. (RBCC), via wholly owned subsidiary Rainbow Biosciences, continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. The company specifically pursues opportunities that offer short-term marketability and commercialization potential in key areas like Alzheimer's, Parkinson's, and Cancer.
Bioscience technology is a growing, dynamic field of innovation that applies life processes to practical uses, such as the manufacturing of medical devices and the development of new bioscience procedures. From pharmaceuticals to pacemakers, genetically engineered plants to gene therapy, bioscience technology can be found virtually anywhere.
The pending joint venture with Amarantus BioScience to develop and market new therapies and treatments for neurological diseases and physical traumas is a great example of the initiatives underway. In recent news, Amarantus licensed a highly promising diagnostic blood test that could become an invaluable new tool in Alzheimer's clinical trials where patient recruitment errors occur often due to inaccurate diagnosis.
The global biotech industry, currently valued at more than $84.6B, allows new players with bright ideas to quickly grab market share and create completely new markets. The exciting initiatives being driven forward by Rainbow Coral promise to transition today's leading-edge research into practical, affordable treatments for people who need them most. Disclaimer
Rainbow Coral Corp. Company Blog
Rainbow Coral Corp. News:
RBCC to Drive Growth Through Personalized Medicine
RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
RBCC Partner n3D Signs U.S. Distribution Agreement
VentriPoint Diagnostics Ltd. (VPTDF)
The QualityStocks Daily Newsletter would like to spotlight VentriPoint Diagnostics Ltd. (VPTDF). Today, VentriPoint Diagnostics Ltd. closed trading at $0.09, even for the day. The stock’s average daily volume over the past 60 days is 16,839, and its 52-week low/high is $0.073/$0.163.
VentriPoint Diagnostics Ltd. announced today that they have hired Mr. Jerry Gatewood as its Vice-President of Sales and Marketing, bringing over 18 years of experience introducing new medical products, with extensive experience in sales and marketing of imaging equipment. "It is with great pleasure that I welcome Jerry to the team" said Dr. George Adams, CEO of Ventripoint. "Jerry's 'been-there-done-that' wisdom will lead us as we prepare for expanding sales into the U.S. and the rest of the world."
VentriPoint Diagnostics Ltd. (VPTDF) leverages knowledge-based techniques to make heart analysis more convenient and less expensive. Having already installed multiple VMS™ analysis systems for heart testing in leading cardiac centers in Europe, Canada and the United States, the company is currently focused on expanding the applications of its technology beyond congenital heart disease in adults and children.
VMS™ is the first cost-effective and accurate diagnostic tool for measuring right ventricle heart function. The company designed its analysis system to be used for all major heart diseases, including pulmonary hypertension, cardiovascular disease, and heart failure. Canada and Europe (CE Mark) have granted approval for the sale of the VMS™ diagnostic tool, and VentriPoint is pursuing the US-FDA approval through the 510(k) process.
The company’s VMS™ analysis systems eliminate all the disadvantages of an MRI scan, including a long wait list, the one-hour scan time, the claustrophobic environment, the requirement of a general anesthetic for children, the lengthy heart analysis process, and the need for a second trip to the hospital. Offering better efficiency and cost savings, VMS™ offers the healthcare industry a superior method of heart visualization.
The management team executing VentriPoint’s business strategy retains extensive experience in both healthcare technology and business development. Many expansion opportunities exist for the company’s technology with a total market potential exceeding $1 billion. As a leader in the clinical diagnostics market, the company is well positioned to meet the well-defined clinical need for efficient, accurate, and inexpensive heart analysis. Disclaimer
VentriPoint Diagnostics Ltd. Company Blog
VentriPoint Diagnostics Ltd. News:
Ventripoint Announces New Vice-President of Sales and Marketing
VentriPoint Announces Closing of Private Placement and Proposed Issuance of Shares for Debt
VentriPoint Announces Private Placements
DoMark International, a leading investment management company focused on patented or patent pending mass market consumer products, today announced that it has initiated the design development of its new revolutionary lightweight infrared and solar panel charger case with a built-in back up lithium battery for the Apple iPad.
The new accessory, called IRiPAD Charger, will be the second product developed by DoMark for the Apple iPad. Unlike other chargers, DoMark’s product utilizes patented infrared and solar technology designed to improve functionality for the heavy user. By taking advantage of new landmark technology and incorporating a sophisticated light-weight design, the company anticipates achieving great success in the $2.3 billion iPad accessories market.
DoMark has already developed an infrared/solar charger case for the Apple iPhone and Samsung Galaxy III and S4 Smartphones which are to be launched in August 2013. The company also recently invested in privately held Imagic Ltd., which has produced a pioneering product for the gaming enthusiast with a planned launch for the Christmas season this year.
DoMark invests and develops in next-generation mass market consumer products for the explosive global Smartphone market, competing against Quantum International Corporation (QUAN) and Dover Corp. (DOV).
“This new product will add to the Company’s exciting new range of innovative products,” DoMarks Chief Executive Officer stated. “This is an exciting time for DoMark as our range of products are very well positioned to maximize global sales in this ever expanding market place”.
For more information on DoMark International, visit www.domarkintl.com
International Stem Cell, a biotech company focused on developing novel stem cell-based therapies, has initiated its IND-enabling pharmacology and toxicology non-human primate studies directed by Yale School of Medicine Professor D. Eugene Redmond Jr. MD, an internationally recognized neurosurgeon and a leader in the use of stem cells for the treatment of Parkinson’s disease.
The studies will assess the safety and efficacy of ISCO’s proprietary stem cell-derived neuronal cells when administered to non-human primates with moderate to severe Parkinson’s disease symptoms. Established endpoints of these multi-dose studies are to determine cell fate, biodistribution, and primate behavioral evaluations using a standardized rating scale to assess potential extrapyramidal side effects associated with the cell engraftment.
In his career of more than 25 years, Professor Redmond has become a recognized expert in the use of transplanted neural cells to treat parkinsonism in primates and the development of effective replacement strategies using stem cell derived neurons. In addition, he has established one of the first preclinical models for Parkinson’s disease in primates, the first successful transplantation of fetal tissue into the brain of a primate, and one of the first clinical studies of fetal tissue in Parkinson’s patients.
Dr. Ruslan Semechkin, vice president of ISCO’s R&D, referenced positive data from the company’s recent, successful primate and rodent studies, and said that under the leadership and knowledge of Professor Redmond, the upcoming formal studies will be final step for ISCO to file an IND for Parkinson’s disease.
“As one of the leaders in this field, it’s tremendously exciting for ISCO to have such an experienced and influential clinical scientist as Prof. Redmond to direct this research. His clinical experience will be invaluable as we prepare both our IND submission to the FDA and the subsequent phase I clinical trial,” Dr. Semechkin stated in the press release.
ISCO expects interim results in the fourth quarter of 2013 with the final results available in the second quarter of 2014.
For more information, visit www.internationalstemcell.com
Today before the opening bell, Rainbow Coral Corp. announced that it is making plans to empower patients to demand better care through both innovation and education as the company sets its sights on the fast-growing, $232 billion personalized medicine market.
By delivering new technologies in the sectors of the personalized medicine field expected to see the most growth, Rainbow Coral hopes to arm patients with more effective and efficient treatment options than ever before. But, according to today’s press release, bringing new ideas and products to the marketplace is only one piece of the company’s expansion strategy.
“Our ultimate goal is to help spur patient-driven demand for personalized medicine,” RBCC CEO Patrick Brown stated. “That requires not just delivering new innovations, but helping to educate patients on these promising new treatment options. That’s why we’re developing a comprehensive media and marketing strategy.”
PricewaterhouseCoopers projects that the personalized medicine market in the U.S. could grow to as much as $452 billion by 2015. One of the fastest-growing fields in the market is companion diagnostics, an area of RBCC’s focus, which could grow to as large as $42 billion by 2015, according to industry analysts TriMarkPublications.com.
For more information, visit www.rainbowbiosciences.com
Ventripoint Diagnostics today reported the appointment of Mr. Jerry Gatewood as its Vice-President of Sales and Marketing.
Gatewood brings more than 18 years of introducing new medical products with extensive experience in sales and marketing of imaging equipment. He was Global Market Manager for ATL Ultrasound (now Philips Medical Systems), where he created and executed global marketing and market introduction plans, and Director of U.S. Marketing for SonoSite (now part of FujiFilm) where he managed the U.S. marketing team and identified and developed new markets. He was also Director for Global Sales for Merge CAD, where he established, negotiated, and managed all aspects of original equipment manufacturer (OEM) partnerships, while securing national U.S. account agreements with major group purchasing organizations.
“It is with great pleasure that I welcome Jerry to the team” said Dr. George Adams, CEO of Ventripoint. “Jerry’s ‘been-there-done-that’ wisdom will lead us as we prepare for expanding sales into the U.S. and the rest of the world.”
“I am very excited at the opportunity to be a part of the Ventripoint team. This Company and its technology have a great potential to positively impact patient care and I am proud to be part of that movement” said Jerry Gatewood, VP of Sales and Marketing.
Mr. Amol Karnick will continue to be a consultant to the company and focus on Business Development.
For additional information, visit www.VentriPoint.com
Today's Top 3
First Penny Picks
Bird Gang Stocks
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Announces Filing of Proxy Statement Supplement and New Annual Meeting Date
- Consorteum Holdings, Inc. (CSRH) Enters Partnership Agreement With KO Entertainment, Inc.
- Cardium Therapeutics, Inc. (CXM) Announces Generx Publication In Molecular Therapy
- DoMark International, Inc. (DOMK) Develops New Product for $2.3 Billion iPad Accessories Market
- GNCC Capital, Inc. (GNCP) Reaches Agreement to Acquire White Hills Gold Properties
- GlobalWise Investments, Inc. (GWIV) Adds Toshiba Business Solutions AZ/CO as New Channel Sales Partner
- International Stem Cell Corp. (ISCO) Initiates IND-Enabling Study in Parkinson's Disease Program
- Loans4Less.com, Inc. (LFLS) CEOCFO Magazine Interview Highlights Solid Market Position
- Low Carbon Technologies International, Inc. (LWCTF) Plans to Announce 6 Month YTD Financials
- Mabwe Minerals Inc. (MBMI) Announces Engagement of QualityStocks Investor Relations Services
- Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
- Rainbow Coral Corp. (RBCC) to Drive Growth Through Personalized Medicine
- Raptor Resources Holdings Inc. (RRHI) Mabwe Minerals Shareholder Report Card
- Solar Wind Energy Tower, Inc. (SWET) Receives Notice of Allowance of Patent titled "Atmospheric Energy Extraction Devices and Methods"
- StreamTrack, Inc. (STTK) Announces Alliance to Potentially Reach Over 300 Million Registered PPTV Users
- The Aristocrat Group Corp. (ASCC) Formulates Plans to Capitalize on Successful Vodka Launch
- The Guitammer Company Inc. (GTMM) Goes Supersonic!
- VentriPoint Diagnostics Ltd. (VPTDF) Announces New Vice-President of Sales and Marketing
- Viaspace, Inc. (VSPC) and AGRICORP Sign Joint Development Agreement for 12 MW Power Plant Co-located with 2,100 acre Giant King Grass Plantation in Nicaragua
- VistaGen Therapeutics, Inc. (VSTA) and Duke University Publish Results on Production of Functional 3D Human Heart Tissue